This study will assess short and long term outcomes of individuals undergoing minimally invasive surgery of the gastro-esophageal junction (MISGEJ). Patients will respond to questionnaires on an annual basis evaluating quality of life and functionality following MISGEJ. Hospital charts will also be reviewed on an annual basis to assess patient health outcomes.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* All patients at the Ottawa Hospital undergoing minimally invasive surgery of the GEJ
Exclusion Criteria:
* Less than 18 years of age.
Primary outcome measure(s)
MISGEJ symptoms (subjective) — 8 years MISGEJ symptom questionnaire evaluated on an annual basis
Achalasia Disease Severity (subjective) — 8 years Achalasia Disease Severity questionnaire evaluated on an annual basis.
Diagnostic imaging — 8 years Patient x-rays, upper GI tests, Endoscopy, and/or CT scans will be assessed on an annual basis to objectively measure functionality and health status.
Trial sites (1)
Facility
City
Region
Status
Ottawa Hospital Research Institute
Ottawa
Ontario
More Ottawa Hospital Research Institute trials in Canada
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.